BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35255496)

  • 41. Tyrosine phosphorylation of Shc is mediated through Lyn and Syk in B cell receptor signaling.
    Nagai K; Takata M; Yamamura H; Kurosaki T
    J Biol Chem; 1995 Mar; 270(12):6824-9. PubMed ID: 7896829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
    Phelan JD; Young RM; Webster DE; Roulland S; Wright GW; Kasbekar M; Shaffer AL; Ceribelli M; Wang JQ; Schmitz R; Nakagawa M; Bachy E; Huang DW; Ji Y; Chen L; Yang Y; Zhao H; Yu X; Xu W; Palisoc MM; Valadez RR; Davies-Hill T; Wilson WH; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Rodriguez FJ; Estephan F; Holdhoff M; Kruhlak MJ; Hewitt SM; Thomas CJ; Pittaluga S; Oellerich T; Staudt LM
    Nature; 2018 Aug; 560(7718):387-391. PubMed ID: 29925955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b.
    Han C; Jin J; Xu S; Liu H; Li N; Cao X
    Nat Immunol; 2010 Aug; 11(8):734-42. PubMed ID: 20639876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of p73 by Hck through kinase-dependent and independent mechanisms.
    Paliwal P; Radha V; Swarup G
    BMC Mol Biol; 2007 May; 8():45. PubMed ID: 17535448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas.
    Hatton O; Phillips LK; Vaysberg M; Hurwich J; Krams SM; Martinez OM
    J Biol Chem; 2011 Oct; 286(43):37368-78. PubMed ID: 21908615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of src-related tyrosine kinases by IL-3.
    Anderson SM; Jorgensen B
    J Immunol; 1995 Aug; 155(4):1660-70. PubMed ID: 7636226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SYK and LYN mediate B-cell receptor-independent calcium-induced apoptosis in DT-40 lymphoma B-cells.
    Zhu DM; Tibbles HE; Vassilev AO; Uckun FM
    Leuk Lymphoma; 2002 Nov; 43(11):2165-70. PubMed ID: 12533043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism.
    Mansueto MS; Reens A; Rakhilina L; Chi A; Pan BS; Miller JR
    J Biol Chem; 2019 May; 294(19):7658-7668. PubMed ID: 30923129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical and functional association of the high affinity immunoglobulin G receptor (Fc gamma RI) with the kinases Hck and Lyn.
    Wang AV; Scholl PR; Geha RS
    J Exp Med; 1994 Sep; 180(3):1165-70. PubMed ID: 8064233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The regulation of the expression of inducible nitric oxide synthase by Src-family tyrosine kinases mediated through MyD88-independent signaling pathways of Toll-like receptor 4.
    Lee JY; Lowell CA; Lemay DG; Youn HS; Rhee SH; Sohn KH; Jang B; Ye J; Chung JH; Hwang DH
    Biochem Pharmacol; 2005 Oct; 70(8):1231-40. PubMed ID: 16140274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomics, Signaling, and Treatment of Waldenström Macroglobulinemia.
    Hunter ZR; Yang G; Xu L; Liu X; Castillo JJ; Treon SP
    J Clin Oncol; 2017 Mar; 35(9):994-1001. PubMed ID: 28294689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncogenically active MYD88 mutations in human lymphoma.
    Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
    Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulation.
    Liu Y; Bezverbnaya K; Zhao T; Parsons MJ; Shi M; Treanor B; Ehrhardt GR
    J Immunol; 2015 Jun; 194(12):5851-60. PubMed ID: 25972488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative.
    Chakraborty MP; Bhattacharyya S; Roy S; Bhattacharya I; Das R; Mukherjee A
    J Biol Chem; 2021; 296():100449. PubMed ID: 33617879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Syk and Lyn mediate distinct Syk phosphorylation events in FcɛRI-signal transduction: implications for regulation of IgE-mediated degranulation.
    Sanderson MP; Wex E; Kono T; Uto K; Schnapp A
    Mol Immunol; 2010; 48(1-3):171-8. PubMed ID: 20828828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.
    Hu Y; Liu Y; Pelletier S; Buchdunger E; Warmuth M; Fabbro D; Hallek M; Van Etten RA; Li S
    Nat Genet; 2004 May; 36(5):453-61. PubMed ID: 15098032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.
    Gobessi S; Laurenti L; Longo PG; Sica S; Leone G; Efremov DG
    Blood; 2007 Mar; 109(5):2032-9. PubMed ID: 17038529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia.
    Liu A; Gong P; Hyun SW; Wang KZ; Cates EA; Perkins D; Bannerman DD; Puché AC; Toshchakov VY; Fang S; Auron PE; Vogel SN; Goldblum SE
    J Biol Chem; 2012 May; 287(20):16132-45. PubMed ID: 22447928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth.
    Gururajan M; Dasu T; Shahidain S; Jennings CD; Robertson DA; Rangnekar VM; Bondada S
    J Immunol; 2007 Jan; 178(1):111-21. PubMed ID: 17182546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.